Pharmaceutical giant Pfizer (PFE) reported mixed quarterly numbers Tuesday morning. They beat on EPS but revenues disappointed and traders do not seem happy with their 2022 guidance. Let's check on the charts and technical indicators.
More from Investing
Think you can own big tech? You might just get an 'F' for that. Here's what will get you on the other side of this year.
A limited rally cooled some of the negativity on the market, but guess what's going to hit the fan soon?
Let's check the charts on this biotechnology stock and see if it still has a prayer.